Intec stock plunges 80% after late-stage failure of Parkinson’s drug – MarketWatch

Intec stock plunges 80% after late-stage failure of Parkinson’s drug – MarketWatch
Intec stock plunges 80% after late-stage failure of Parkinson's drug  MarketWatchShares of biotech Intec Pharma Ltd. plunged 80% in premarket trade Monday after the company said its late-stage trial of a drug meant to treat symptoms of ... read more
Source: Google NewsPublished on 2019-07-22